AU2722292A - Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods - Google Patents

Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods

Info

Publication number
AU2722292A
AU2722292A AU27222/92A AU2722292A AU2722292A AU 2722292 A AU2722292 A AU 2722292A AU 27222/92 A AU27222/92 A AU 27222/92A AU 2722292 A AU2722292 A AU 2722292A AU 2722292 A AU2722292 A AU 2722292A
Authority
AU
Australia
Prior art keywords
ultrasound
methods
ray imaging
contrast agents
encapsulated particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27222/92A
Inventor
Denis Mahlon Bailey
Robert Owen James
Joseph Samuel Yudelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of AU2722292A publication Critical patent/AU2722292A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0476—Particles, beads, capsules, spheres
    • A61K49/0485—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A61K49/049—Surface-modified nanoparticles, e.g. immune-nanoparticles
AU27222/92A 1991-11-21 1992-10-22 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods Abandoned AU2722292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US795590 1985-11-06
US07/795,590 US5233995A (en) 1991-11-21 1991-11-21 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods

Publications (1)

Publication Number Publication Date
AU2722292A true AU2722292A (en) 1993-05-27

Family

ID=25165928

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27222/92A Abandoned AU2722292A (en) 1991-11-21 1992-10-22 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods

Country Status (9)

Country Link
US (1) US5233995A (en)
EP (1) EP0543454A3 (en)
JP (1) JPH05306239A (en)
AU (1) AU2722292A (en)
CA (1) CA2083109A1 (en)
FI (1) FI925284A (en)
HU (1) HUT67156A (en)
MX (1) MX9206698A (en)
NO (1) NO924481L (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2112109A1 (en) * 1991-07-05 1993-01-21 Arne Berg Improvements in or relating to contrast agents
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US20070117862A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
GB9303992D0 (en) * 1993-02-26 1993-04-14 Nycomed Imaging As Contrast agents
US5330740A (en) * 1993-03-01 1994-07-19 Sterling Winthrop Inc. Compositions of iodoaniline derivatives in film-forming materials for visualization of the gastrointestinal tract
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5611342A (en) * 1994-02-15 1997-03-18 Molecular Biosystems, Inc. Method of computer tomography imaging the gastrointestinal tract and surrounding upper abdominal tissues and organs using an orally administered low density contrast medium
US5368837A (en) * 1994-04-14 1994-11-29 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivative
US5567410A (en) * 1994-06-24 1996-10-22 The General Hospital Corporation Composotions and methods for radiographic imaging
US5622687A (en) * 1994-11-15 1997-04-22 Molecular Biosystems, Inc. Calixarene conjugates useful as MRI and CT diagnostic imaging agents
AU4867296A (en) * 1995-02-14 1996-09-04 Nanosystems L.L.C. Process of preparing lymphography contrast agents
US5543133A (en) * 1995-02-14 1996-08-06 Nanosystems L.L.C. Process of preparing x-ray contrast compositions containing nanoparticles
US5573750A (en) * 1995-05-22 1996-11-12 Nanosystems L.L.C. Diagnostic imaging x-ray contrast agents
US5955143A (en) * 1995-12-21 1999-09-21 Drexel University Hollow polymer microcapsules and method of producing the same
US8137684B2 (en) 1996-10-01 2012-03-20 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EP1023050B1 (en) * 1997-06-27 2013-09-25 Abraxis BioScience, LLC Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
US7378081B2 (en) 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128301A (en) * 1953-12-17 1964-04-07 Sterling Drug Inc Alkyl esters of acylated 3,5-diamino- 2, 4, 6-triiodobenzoic acids and their preparation
US3119858A (en) * 1957-04-17 1964-01-28 Sterling Drug Inc Iodinated esters of substituted benzoic acids and preparation thereof
SE420565B (en) * 1974-06-06 1981-10-19 Pharmacia Ab AID FOR INTRAVASCULAR ADMINISTRATION FOR USE IN CONNECTION WITH INTRAVASCULAR ADMINISTRATION OF A SOLUTION OR SUSPENSION OF A DIAGNOSTIC AGENT
US4376802A (en) * 1980-01-24 1983-03-15 Allied Corporation Finish composition for polyester yarn
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
SE463651B (en) * 1983-12-21 1991-01-07 Nycomed As DIAGNOSTIC AND CONTRACTOR
US4567034A (en) * 1984-09-07 1986-01-28 E. R. Squibb & Sons, Inc. Esters of diatrizoic acid as X-ray contrast agents
US4844882A (en) * 1987-12-29 1989-07-04 Molecular Biosystems, Inc. Concentrated stabilized microbubble-type ultrasonic imaging agent
IE61591B1 (en) * 1987-12-29 1994-11-16 Molecular Biosystems Inc Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
US5238714A (en) * 1990-10-02 1993-08-24 Board Of Regents, The University Of Texas System Efficient microcapsule preparation and method of use

Also Published As

Publication number Publication date
NO924481D0 (en) 1992-11-20
CA2083109A1 (en) 1993-05-22
JPH05306239A (en) 1993-11-19
FI925284A (en) 1993-05-22
EP0543454A3 (en) 1994-05-25
FI925284A0 (en) 1992-11-20
HU9203637D0 (en) 1993-01-28
HUT67156A (en) 1995-02-28
NO924481L (en) 1993-05-24
EP0543454A2 (en) 1993-05-26
MX9206698A (en) 1993-05-01
US5233995A (en) 1993-08-10

Similar Documents

Publication Publication Date Title
AU2722292A (en) Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods
IL103951A0 (en) Contrast agents for ultrasound imaging and their preparation
AU5491290A (en) Perfume particles for use in cleaning and conditioning compositions
EP0727225A3 (en) Compositions and methods for directed ultrasound imaging
AU4471896A (en) Oral gastrointestinal x-ray contrast agents in combination with surfactants
AU4764396A (en) Calcium/oxyanion-containing particles for use in medical diagnostic imaging
HK33294A (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
AU1123292A (en) Fat simulating composition containing carbohydrate gel particles
AU5076890A (en) Cleaning compositions and methods
EP0546728A3 (en) Physiological tear compositions and methods for their preparation
EP0542914A4 (en) Improved diagnostic and therapeutic compositions
GB9116472D0 (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
HK152495A (en) Fluoride colloid and oral composition
IL114572A0 (en) Benzamine pharmaceutical compositions containing it its preparation and use
HK1007551A1 (en) Basic aluminium antiperspirant active materials antiperspirant active compositions comprising the same and method for the preparation thereof
IL114145A0 (en) Non-reducing saccharides their preparation compositions containing them and their use
AU3831693A (en) X-ray contrast compositions and methods for their use in the visualization of the GI tract
EP0410974A4 (en) Nonionic x-ray contrast agents, compositions and methods
AU2908092A (en) Contrast agents and compositions for radiological imaging, and radiological imaging method utilizing same
IL117395A0 (en) Bicyclic compounds preparation thereof and use in pharmaceutical compositions
AU1464595A (en) Oral magnetic particle formulation
IL107130A0 (en) Iodinated wetting agents and x-ray contrast compositions comprising them
AU1173892A (en) Compositions for use in dentistry
AU7982091A (en) Clot imaging agents and use thereof
AU5093993A (en) Nonionic X-ray contrast agents compositions and methods